FIELD: medicine; laser therapy. SUBSTANCE: method includes determination of variation of erythrocyte deforming capacity under effect of different-power laser radiation in vitro. Then loss of laser radiation is determined when it passes through skin above irradiated vessel. Laser irradiation dose required for better therapeutic effect is determined with due regard for maximum improvement of erythrocyte deforming capacity and laser radiation losses when passing through skin above irradiated vessel. EFFECT: laser therapy optimization. 1 cl, 1 tbl, 1 ex
Authors
Dates
1999-02-27—Published
1996-02-21—Filed